Study of Botulinum Toxin in Patients With Primary Hyperhidrosis

Icahn School of Medicine at Mount Sinai

Overview

OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.

PROTOCOL OUTLINE: Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Conditions

Hyperhidrosis

Interventions

botulinum toxin type ADRUG

Eligibility

Sex: ALLMin age: 16 Years

Medical Language ↔ Plain English

* Diagnosis of hyperhidrosis * Excessive sweating in the hands, feet, armpits, forehead, or body

Locations (1)

Mount Sinai School of Medicine

New York, New York, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.